Comparing delirium rates from different anesthetics in liver transplant patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the incidence of postoperative delirium in patients undergoing liver transplantation. It focuses on comparing the effects of two anesthetic agents: the inhalational anesthetic sevoflurane and the intravenous anesthetic propofol. By analyzing patient outcomes, the study aims to identify which anesthetic may be associated with a lower incidence of delirium. The study will include adults aged 19 and older who are scheduled for liver transplantation and will exclude individuals with certain cognitive impairments or neurological disorders.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 19 years and older
* Patients undergoing liver transplantation who are scheduled to receive anesthesia with the inhaled anesthetic sevoflurane or the intravenous anesthetic propofol.

Exclusion Criteria:

* Individuals with hearing loss, cognitive impairment or obvious dementia, hepatic encephalopathy, or difficulty in communication.
* Diagnosed with neurological disorders (e.g., brain hemorrhage, stroke, dementia, Parkinson's disease, cognitive impairment, etc.).

Where it's running

• Department of Anesthesiology and Pain Medicine Yonsei University College of Medicine
  Seoul, South Korea Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Assessing muscle loss and liver health in patients with advanced liver disease

  This study is testing how muscle loss affects liver health in people with advanced liver disease by looking at their body composition and overall well-being over two years.

  Recruiting at 3 sites Linkoeping University · Eksjö and 2 other locations · NCT05502198

• Blood test for detecting liver cancer and cirrhosis

  This study is testing a new blood test to see if it can help detect liver cancer and cirrhosis in people who have or are being checked for liver issues.

  Recruiting at 7 sites Helio Genomics · Escondido, California and 6 other locations · NCT05199259

• Using spleen size to help detect gastroesophageal varices in compensated cirrhosis

  This study tests whether ultrasound measurements of spleen size can help identify esophageal varices in adults with compensated cirrhosis, compared with the standard endoscopy test.

  Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University · Zhuhai, Guangdong · NCT07920744

• InstaSure Non-Invasive Finger-Press Test for HCC

  This study tests a non-invasive finger-skin test to help identify hepatocellular carcinoma in adults.

  Recruiting Beijing Municipal Administration of Hospitals · Beijing, Beijing Municipality · NCT07848750

• BGB-B2033 vs Sorafenib or Lenvatinib for advanced liver cancer

  This study tests whether the investigational drug BGB-B2033 can help people with advanced hepatocellular carcinoma when given after prior PD-1/PD-L1 therapy, compared with the standard medicines sorafenib or lenvatinib.

  Recruiting at 2 sites Phase 3 BeOne Medicines · South Brisbane, Queensland and 1 other locations · NCT07836530

• Laparoscopic liver and spleen removal for small liver cancer in people with cirrhosis and enlarged spleen

  This study tests whether removing part of the liver and the spleen during one operation helps people with small liver cancers and hypersplenism by improving liver function and immune balance.

  Recruiting Northern Jiangsu People's Hospital · Yangzhou, Jiangsu · NCT07811687

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.